High Cost of Immunotherapy Linked to Financial Hardship Among Cancer Survivors
5 Articles
5 Articles
High cost of immunotherapy linked to financial hardship among cancer survivors
A study published today in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy treatments were more likely to face financial hardship, leading to increased instances of being unable to afford care and taking fewer medications due to cost.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
A study published in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy treatments were more likely to face financial hardship, leading to increased instances of being unable to afford care and taking fewer medications due to cost.
Study Reveals Financial Hardship for Cancer Survivors Due to High-Cost Immunotherapies, Especially Among Blood Cancer Patients
A study published today in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy treatments were more likely to face financial hardship, leading to increased instances of being unable to afford care and taking fewer medications due to cost.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage